Delivra Health Brands Inc. faced a significant setback in its stock performance, dropping over 15% in a single trading session.
Delivra Health Brands Inc. (DHB.V) experienced a sharp decline in its stock price yesterday, closing at CA$0.11 after a staggering drop of 15.38%. This downturn raises concerns about the company's market position and investor confidence.
Advertisement
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$3.44M
52W high
$0.37
52W low
$0.09
1W change
-8.33%
Beta
0.89
Analyst Price Targets
Based on analyst covering DHB
Wall Street analysts forecast DHB stock price to rise 381.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.53
+381.8% Upside
Current Price
C$0.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
148.0%
Annualized
90-Day Vol
128.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.06 – C$0.17 |
| 60 trading days | C$0.10 | C$0.05 – C$0.20 |
| 90 trading days | C$0.09 | C$0.04 – C$0.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Delivra Health Brands for signs of recovery or further declines, especially given its recent performance and market cap of just CA$3.44 million.
Stock Plummets 15.38%
Delivra Health Brands' market cap now sits at a mere CA$3.44 million, highlighting its vulnerability in the current market.
Bull case
If Delivra can successfully leverage its recent product launches, like LivRelief™ Itch Relief Cream, it might regain investor confidence and drive future growth. The company has potential, and if it can turn its recent innovations into sales, it could bounce back.
Bear case
The sharp decline in stock price suggests that investors are wary of Delivra's financial health, especially with its negative profit margin and lack of recent positive news. This uncertainty could lead to further declines if the company doesn’t show signs of improvement soon.
Market Reaction
Advertisement
The 15.38% drop in Delivra Health Brands' stock price reflects a broader sentiment of uncertainty among investors. With a market cap of CA$3.44 million, the company is under significant pressure to demonstrate growth and profitability.
Financial Health Concerns
Delivra's negative profit margin of -0.0899 raises red flags about its financial sustainability. Investors are advised to consider the implications of this metric alongside the company's recent product launches, which have yet to translate into positive financial results.
Looking Ahead
As Delivra Health Brands navigates this challenging period, stakeholders should remain vigilant. The company's ability to innovate and effectively market its products will be crucial in determining its future stock performance and overall market viability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
